Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 186 for lung disease

Edit search filters
  1. A Phase 3 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of L606 in Subjects With PAH

    Jacksonville, FL

  2. A Study to Evaluate Progenitor Cells for Patients with Degenerative Lung Disease

    Rochester, MN

  3. Lung Ultrasound for Identification of Pulmonary Edema in Adults With Congenital Heart Disease

    Rochester, MN

  4. Psychological Well-Being and Physical Activity in Patients with Fibrotic Interstitial Lung Disease

    Rochester, MN

  5. Recording Breath Acoustics and Lung Mechanics in Patients with COPD, Asthma, and Cystic Fibrosis

    Scottsdale/Phoenix, AZ

  6. A Study of the Effects of Preterm Birth on Lung Disease and Innate Immunity Later in Life

    Rochester, MN

  7. Chronic Obstructive Pulmonary Disease (COPD) in Patients Hospitalized for Acute Decompensated Heart Failure

    Rochester, MN

  8. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  9. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study of Determinants of Patient Activation Level of People Living with Chronic Obstructive Pulmonary Disease (COPD)

    Rochester, MN

.

Mayo Clinic Footer